Prospective Cohort Study of Trastuzumab Biosimilar CT-P6 in HER2-Positive Gastric Cancer: Japanese Real-World Outcomes

Authors

Institutions

Publication Details

Journal
Oncology and Therapy
Published
2025-05-08
DOI
https://doi.org/10.1007/s40487-025-00341-7
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prospective Cohort Study of Trastuzumab Biosimilar CT-P6 in HER2-Positive Gastric Cancer: Japanese Real-World Outcomes

Tatsuji Haneji, Kiyohiro Nishikawa, Hiroya Taniguchi, Hironori Yamaguchi et al.
Oncology and Therapy
HER2/EGFR in Cancer Research
article

Prospective Cohort Study of Trastuzumab Biosimilar CT-P6 in HER2-Positive Gastric Cancer: Japanese Real-World Outcomes

Tatsuji Haneji, Kiyohiro Nishikawa, Hiroya Taniguchi, Hironori Yamaguchi, Hiroshi Imamura, Naoki Izawa
article en

Abstract

No abstract available for this paper.
Oncology and TherapyVol. 13(2)
Jichi Medical University (JP), St. Marianna University School of Medicine (JP), Toyonaka Municipal Hospital (JP), Nishikawa Hospital (JP), Aichi Cancer Center (JP), Nippon Kayaku (Japan) (JP)
Nippon Kayaku
Zero hunger
Openalex Percentile: Top 85%
HER2/EGFR in Cancer Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.